news 
Ethereum Rival Injective Rises, Solana Slips, But BlockDAG’s $0.0018 Offer Could Deliver 2,600% ROI!
Injective (INJ) is on the rise, with its total value locked (TVL) surging by a staggering 22%, reaching an unprecedented $165 million mark. This unprecedented growth in confidence echoes sentiment among developers and users alike, affirming Injective’s competitive edge against other Ethereum rivals. On the flip side, Solana (SOL) is facing a setback, plummeting from $150 to approximately $135 within the last 24 hours. This downfall has placed SOL below its short-term support level of $138, paving the way for another potential decline towards $120.
Meanwhile, BlockDAG presents a contrasting scenario. In a move that defies market trends, BDAG’s price remains frozen at an astonishingly low $0.0018 until June 20 and has been confirmed to launch at $0.05, yielding an unbridled return of 2,600%. This extraordinary value proposition is further underscored by the project’s extensive infrastructure development.
On a technical front, BDAG boasts a live EVM testnet with transaction speeds of up to 15,000 per second. Additionally, the network has secured integrations with a staggering 20 exchanges and garnered support from 2 million mobile miners through its X1 app, signifying a well-established foundation prior to public listing. This remarkable momentum can be attributed to BDAG’s innovative approach towards securing liquidity, fostering culture, and integrating cutting-edge technology.
In conclusion, while Injective continues to exhibit positive market indicators, Solana is currently facing significant pressure with the possibility of further decline. Conversely, BlockDAG has created a unique window for early adopters to capitalize on an extraordinary 2,600% potential ROI at its discounted price of $0.0018 prior to the confirmed launch at $0.05.
Presale Link: https://purchase.blockdag.network
Source: crypto-economy.com
